- Home
- NBHC vs ELVN Comparison
NBHC vs ELVN Comparison
Compare NBHC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBHC
- ELVN
- Stock Information
- Founded
- NBHC 2009
- ELVN 2016
- Country
- NBHC United States
- ELVN United States
- Employees
- NBHC N/A
- ELVN N/A
- Industry
- NBHC Major Banks
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- NBHC Finance
- ELVN Health Care
- Exchange
- NBHC Nasdaq
- ELVN Nasdaq
- Market Cap
- NBHC 1.4B
- ELVN 1.2B
- IPO Year
- NBHC 2012
- ELVN 2020
- Fundamental
- Price
- NBHC $36.61
- ELVN $22.27
- Analyst Decision
- NBHC Hold
- ELVN Strong Buy
- Analyst Count
- NBHC 5
- ELVN 5
- Target Price
- NBHC $46.00
- ELVN $41.20
- AVG Volume (30 Days)
- NBHC 361.9K
- ELVN 535.6K
- Earning Date
- NBHC 10-21-2025
- ELVN 11-12-2025
- Dividend Yield
- NBHC 3.17%
- ELVN N/A
- EPS Growth
- NBHC N/A
- ELVN N/A
- EPS
- NBHC 3.09
- ELVN N/A
- Revenue
- NBHC $399,531,000.00
- ELVN N/A
- Revenue This Year
- NBHC $8.33
- ELVN N/A
- Revenue Next Year
- NBHC $23.76
- ELVN $20.05
- P/E Ratio
- NBHC $12.27
- ELVN N/A
- Revenue Growth
- NBHC N/A
- ELVN N/A
- 52 Week Low
- NBHC $32.83
- ELVN $13.30
- 52 Week High
- NBHC $51.76
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- NBHC 37.35
- ELVN 62.01
- Support Level
- NBHC $36.62
- ELVN $19.98
- Resistance Level
- NBHC $38.43
- ELVN $21.81
- Average True Range (ATR)
- NBHC 0.91
- ELVN 0.92
- MACD
- NBHC -0.19
- ELVN 0.21
- Stochastic Oscillator
- NBHC 9.01
- ELVN 99.38
About NBHC National Bank Holdings Corporation
National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.